drugset / Trial / NCT04181606

Age Comparisons of Exercising Muscle O2 Supply in Healthy Adults: Effects of Esmolol Infusion

NCT04181606

Phase 0 Completed 30 enrolled David N. Proctor, PhD
RandomizedCrossoverTriple-blindBasic science

Summary

This study will test the central hypothesis that postmenopausal women will demonstrate increased oxygen extraction in active leg muscle during leg cycling exercise while receiving an infusion of Esmolol, a fast-acting β1 selective antagonist, when compared to premenopausal women

Timeline

Start
2022-02-02
Primary completion
2023-04-25
Completion
2023-04-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified 0.25 mg/kg Intravenous

Indications

No indication recorded.